Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Crohn's Disease
Related studies linked through entity extraction aliases.
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- N/A
Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety of Celecoxib in Patients With Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE4
A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.
- Status
- COMPLETED
- Phase
- PHASE3
The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels
- Status
- COMPLETED
- Phase
- PHASE4
Study for the Treatment of Crohn's Disease With Adacolumn
- Status
- COMPLETED
- Phase
- PHASE3
A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).
- Status
- COMPLETED
- Phase
- PHASE3
Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients
- Status
- COMPLETED
- Phase
- N/A
Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- NA
VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE4